Literature DB >> 3769978

Serum levels of ampicillin and gentamycin in neonates of varying gestational age.

L B Dahl, K Melby, T J Gutteberg, G Størvold.   

Abstract

Serum concentrations of gentamycin and ampicillin were investigated at loading and in steady state in two groups of neonates, of 26-33 weeks and 34-40 weeks gestation. At loading the usual intravenous dose of gentamycin (2.5 mg/kg) was increased by 50%, the usual intravenous dose of ampicillin (50 mg/kg) by 100%. Gentamycin and ampicillin were administered subsequently at the same intervals, 12 h in the 34-40 weeks group, and 18 h in the 26-33 weeks group. Adequate serum levels were achieved from the first day of treatment. For practical reasons ampicillin and gentamycin can be administered subsequently at identical intervals also when the intervals exceed 12 h. The ideal dosing interval for gentamycin in very preterm neonates is 24 h. When treating small preterm and term neonates with an aminoglycoside, rapid serum concentration analyses should be available, and the treatment modified accordingly.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3769978     DOI: 10.1007/bf00446070

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  13 in total

1.  Considerations about the relationship of inhibitory concentrations and the pharmacologic and toxic properties of antimicrobial agents.

Authors:  H C Neu
Journal:  Diagn Microbiol Infect Dis       Date:  1983-03       Impact factor: 2.803

2.  Mortality and follow-up data for neonates weighing 500 to 800 g at birth.

Authors:  S Buckwald; W A Zorn; E A Egan
Journal:  Am J Dis Child       Date:  1984-08

3.  Plasma creatinine in the first month of life.

Authors:  H Feldman; J P Guignard
Journal:  Arch Dis Child       Date:  1982-02       Impact factor: 3.791

Review 4.  Netilmicin: clinical pharmacokinetics and aspects on dosage schedules. An overview.

Authors:  G Kahlmeter
Journal:  Scand J Infect Dis Suppl       Date:  1980

Review 5.  Current practices in antimicrobial dosing.

Authors:  H C Neu
Journal:  Rev Infect Dis       Date:  1981 Jan-Feb

6.  Comparison of five methods for the assay of serum gentamicin.

Authors:  R M Ratcliff; C Mirelli; E Moran; D O'Leary; R White
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

7.  Gentamicin in serious neonatal infections: absorption, excretion, and clinical results in 25 cases.

Authors:  J O Klein; M Herschel; R M Therakan; D Ingall
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

8.  Ototoxicity in neonates treated with gentamicin and kanamycin: results of a four-year controlled follow-up study.

Authors:  T Finitzo-Hieber; G H McCracken; R J Roeser; D A Allen; D F Chrane; J Morrow
Journal:  Pediatrics       Date:  1979-03       Impact factor: 7.124

9.  Tobramycin sulfate elimination in premature infants.

Authors:  A M Arbeter; C L Saccar; S Eisner; E Sarni; S J Yaffe
Journal:  J Pediatr       Date:  1983-07       Impact factor: 4.406

10.  Hearing loss in very low birthweight infants treated with neonatal intensive care.

Authors:  S J Abramovich; S Gregory; M Slemick; A Stewart
Journal:  Arch Dis Child       Date:  1979-06       Impact factor: 3.791

View more
  4 in total

1.  Pharmacokinetics of penicillin G in infants with a gestational age of less than 32 weeks.

Authors:  Anouk E Muller; Joost DeJongh; Ymka Bult; Wil H F Goessens; Johan W Mouton; Meindert Danhof; John N van den Anker
Journal:  Antimicrob Agents Chemother       Date:  2007-07-23       Impact factor: 5.191

Review 2.  Antibiotics in neonatal infections: a review.

Authors:  V Fanos; A Dall'Agnola
Journal:  Drugs       Date:  1999-09       Impact factor: 9.546

3.  Amoxicillin pharmacokinetics in preterm infants with gestational ages of less than 32 weeks.

Authors:  J J Huisman-de Boer; J N van den Anker; M Vogel; W H Goessens; R C Schoemaker; R de Groot
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

Review 4.  Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.

Authors:  Jessica K Roberts; Chris Stockmann; Jonathan E Constance; Justin Stiers; Michael G Spigarelli; Robert M Ward; Catherine M T Sherwin
Journal:  Clin Pharmacokinet       Date:  2014-07       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.